Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
about
Inhibitors of apoptosis proteins in human cervical cancer.Targeting survivin in cancer therapyElevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin.Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinomaAssociation of survivin splice variants with prognosis and treatment of breast cancer.Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.Early diagnostic value of survivin and its alternative splice variants in breast cancer.The role of survivin in diagnosis, prognosis and treatment of breast cancer.cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrenceTranscriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancerAlternative splicing and tumor progression.The functioning antigens: beyond just as the immunological targets.Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide.Adenoviral infectivity of exfoliated viable cells in urine: implications for the detection of bladder cancer.The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism.Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene.
P2860
Q25255294-F9840F22-6443-4E22-AAC1-4E3916046FA6Q28273083-0C2FEB10-C4E5-4208-870D-AFB3666D710AQ30320243-1EE5F1E4-0672-435A-A6DC-152D70379861Q34036076-0BAE90D8-24DB-4D08-899B-7C473ACE6331Q34062021-578906B9-A61E-4469-AD96-C6C99C2036DDQ34225286-3BDB7887-80C5-48EA-AEBB-C7835A88ECB8Q34657717-63F5DAA9-0F8F-4CFE-A9F9-5239BCA6F6F3Q34983601-BD8790C2-0076-4226-B718-7AE110ABF4F2Q35118374-4FB56E5C-BDB5-4368-A9DF-075F7B12BFC9Q35667653-1423D1BA-1CE2-453C-969A-1FB233212631Q35769723-8C7E6740-912A-4E19-A4DD-329570F9805AQ36609488-D47C3DEF-541F-4522-879F-F522A7D3B185Q36613564-A65092AC-A6EC-49F7-B96A-6581B3068AB3Q36682871-FCC4D3DF-6625-4269-BB05-A7C5AA4229CDQ37064709-69581CFF-48CA-4B4E-8857-BBACF0090A1EQ37222549-8B9399B3-3EFA-48C9-920B-5B68D20D8D3FQ37222930-A06158F2-12D0-4319-8D62-F54AE02C9B3CQ37483795-825A80D4-00CB-40F3-BA6A-8FAB01547D7AQ38541161-3DA1F0DF-8A83-48EA-AA67-264B3DA7902DQ39275796-B713239E-9080-40A2-BD36-D191E78A5ACAQ39543320-F90C5C8B-8AFF-4FEA-8ACA-6EB679C101E9Q39748012-78563131-C5A2-44D1-BCE3-FEA43178BFC5Q42212985-776422FC-8EE0-45F1-8A89-84446A5A2632Q42949488-FA98CADA-FA5A-4D38-B2BE-84FD535AACA9Q47110708-DEAFB8AF-B2A4-4BDB-B27A-77275162F86EQ52676618-E3D20195-F641-4A49-9EE9-23A3F63D0C7AQ54423844-C23AC9F1-FC19-4D1F-B24C-8364201EAD18
P2860
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@ast
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@en
type
label
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@ast
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@en
prefLabel
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@ast
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@en
P2093
P2860
P356
P1476
Expression of survivin and its ...... vin-DeltaEx3 in breast cancer.
@en
P2093
A D K Hill
E McDermott
N O'Donovan
N O'Higgins
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602314
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1042807847